The study also revealed that aesculetin blocked the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway in gastric cancer cells (Zhang et al., 2021). The gene discussed is AKT1; the disease is gastric cancer.